ArticleOne health (Amsterdam, Netherlands)2019
Shiga toxin-producing
Article in One health (Amsterdam, Netherlands), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 30 citations in OpenAlex.
- Whole-Genome Sequence Analysis of Shiga Toxin-ProducingMicroorganisms · 2026Article
- Pneumo-/enteritis in dromedary camels (Frontiers in veterinary science · 2026Review
- Unveiling the High Diversity of Clones and Antimicrobial Resistance Genes inAntibiotics (Basel, Switzerland) · 2024Article
- Escherichia coli and their potential transmission of carbapenem and colistin-resistant genes in camels.BMC microbiology · 2024Article
- Prevalence, antibiotic sensitivity profile, and phylogenetic analysis ofJournal of advanced veterinary and animal research · 2022Article
- Serotype Diversity and Antimicrobial Resistance Profile ofFrontiers in veterinary science · 2022Article
- Molecular Detection, Serotyping, and Antibiotic Resistance of Shiga ToxigenicAntibiotics (Basel, Switzerland) · 2021Article
- Advanced molecular characterization of enteropathogenicVeterinary world · 2021Article
- Molecular characteristics ofEmerging microbes & infections · 2020Article
- Country Income Is Only One of the Tiles: The Global Journey of Antimicrobial Resistance among Humans, Animals, and Environment.Antibiotics (Basel, Switzerland) · 2020Review
- Article
- Antimicrobial resistant and extended-spectrum ß-lactamase (ESBL) producingScientific African · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Shiga toxin-producing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.